Canopy Growth Corp
TSX:WEED

Watchlist Manager
Canopy Growth Corp Logo
Canopy Growth Corp
TSX:WEED
Watchlist
Price: 1.74 CAD 1.16%
Market Cap: 365.6m CAD

EV/EBIT
Enterprise Value to EBIT

-6.5
Current
-9.3
Median
16.2
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-6.5
=
Enterprise Value
546.1m CAD
/
EBIT
-83.9m CAD
EBIT Growth EV/EBIT to Growth
CA
Canopy Growth Corp
TSX:WEED
Average EV/EBIT: 1 875.7
Negative Multiple: -6.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.7
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.8
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15.2
14%
1.1
CH
Roche Holding AG
SIX:ROG
11.1
6%
1.8
CH
Novartis AG
SIX:NOVN
15
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.6
23%
8.6
US
Merck & Co Inc
NYSE:MRK
11
11%
1
IE
E
Endo International PLC
LSE:0Y5F
737.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
11.1
10%
1.1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-7.6
2-Years Forward
EV/EBIT
-10.8
3-Years Forward
EV/EBIT
-14.1